Stockreport

Navidea Bio +26% premarket on Lymphoseek patent extension [Seeking Alpha]

Cardinal Health, Inc.  (CAH) 
Last cardinal health, inc. earnings: 2/6 06:55 am Check Earnings Report
US:NYSE Investor Relations: ir.cardinalhealth.com/home
PDF Healthcare | On the Move Navidea Bio +26% premarket on Lymphoseek patent extension Mar. 20, 2020 7:37 AM ET Navidea Biopharmaceuticals... (NAVB) Mamta Mayani Navidea Bi [Read more]